Setterwalls advised Mentice AB in connection with a SEK 60 million private placement

Mentice AB has executed a private placement of SEK 60 million through a directed new share issue of 800 000 shares at a price of SEK 75 per share.

Mentice AB has executed a private placement of SEK 60 million through a directed new share issue of 800 000 shares at a price of SEK 75 per share. A large number of Swedish and international institutional investors, including Bure Equity AB, Fjärde AP-fonden (AP4), Handelsbanken Fonder and TIN Fonder, participated in the directed new share issue which was significantly oversubscribed. The subscription price was determined through an accelerated bookbuilding process.

Mentice AB is a global market leader and a company that offers high-tech solutions for simulation to the medical sector with a focus on the fast-growing market for endovascular treatment methods. The company’s solutions assist specialists in the healthcare sector regarding development, management and continuous improvement of competence and technical skills in order to positively influence patient safety and quality in healthcare. Mentice AB’s solutions are scientifically validated and are specifically developed for specialists in the healthcare sector and for the medical technology industry. Neurovascular, cardiology and peripheral intervention are some of the specialty areas covered by the company’s solutions.